Table 5

Correlation of Vimentin mRNA expression with clinical and histopathological parameters

FeaturesTotal
(n=42)
Vimentin mRNA expression
Low
(n=26)
High
(n=16)
P value
Sex
 Male2010 (50%)10 (50%)0.204
 Female2216 (73%)6 (27%)
Age
<60 years2015 (75%)5 (25%)0.121
≥60 years2211 (50%)11 (50%)
Location
 Upper lid3120 (65%)11 (35%)0.304
 Lower lid116 (55%)5 (45%)
TNM Stage*
 IB-IC1615 (94%)1 (6%) 0.002†
 II115 (45%)6 (55%)
 IIIA-IV156 (40%)9 (60%)
Surgery
 Excision3622 (61%)14 (39%)1.000
 Exenteration64 (67%)2 (33%)
Large tumour size
 >2 cm2411 (46%)13 (54%) 0.02†
Differentiation
 Poor1812 (67%)6 (33%)0.75
 Well2414 (58%)10 (42%)
Pagetoid spread148 (57%)6 (43%)0.742
Lymph node metastasis103 (30%)7 (70%) 0.027
Orbital invasion105 (50%)5 (50%)0.465
Recurrence138 (62%)5 (38%)1.000
Tumour-related death101 (100%)0.381
  • *AJCC Staging, 2009.

  • †Significantly associated parameters.

  • mRNA, messenger RNA.